Previous Section
Drug Therapy
1. Lisdexamfetamine dimesylate (Vyvanse) for ADHD.
- Author
- Institution
- Journal
- Med Lett Drugs Ther. 2007 Jul 16;49(1265):58-9.
2. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study.
- Author
- Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Jacobsen SJ;
- Institution
- Department of Pediatric and Adolescent Medicine, Division of Developmental and Behavioral Pediatrics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. barbaresi.william@mayo.edu
- Journal
- J Dev Behav Pediatr. 2007 Aug;28(4):274-87.
- Abstract URL
- Click here to view abstract
3. Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.
- Author
- Brinker A; Mosholder A; Schech SD; Burgess M; Avigan M;
- Institution
- Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA. allen.brinker@fda.hhs.gov
- Journal
- J Child Adolesc Psychopharmacol. 2007 Jun;17(3):328-33.
- Abstract URL
- Click here to view abstract
4. A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.
- Author
- Kratochvil CJ; Vaughan BS; Mayfield-Jorgensen ML; March JS; Kollins SH; Murray DW; Ravi H; Greenhill LL; Kotler LA; Paykina N; Biggins P; Stoner J;
- Institution
- University of Nebraska Medical Center, Omaha, Nebraska, USA. ckratoch@unmc.edu
- Journal
- J Child Adolesc Psychopharmacol. 2007 Apr;17(2):175-85.
- Abstract URL
- Click here to view abstract
5. Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate.
- Author
- Sonuga-Barke EJ; Coghill D; Markowitz JS; Swanson JM; Vandenberghe M; Hatch SJ; Sonuga-Barke EJ; Coghill D; Markowitz JS; Swanson JM; Vandenberghe M; Hatch SJ;
- Institution
- Developmental Brain-Behaviour Unit, University of Southampton, Southampton, UK. ejb3@soton.ac.uk
- Journal
- J Am Acad Child Adolesc Psychiatry. 2007 Jun;46(6):701-10.
- Abstract URL
- Click here to view abstract
6. Update on drugs for hyperactivity in childhood.
- Author
- Institution
- Journal
- Drug Ther Bull. 2007 May;45(5):37-40.
- Abstract URL
- Click here to view abstract
7. Atomoxetine treatment of ADHD in Tourette syndrome: reduction in motor cortex inhibition correlates with clinical improvement.
- Author
- Gilbert DL; Zhang J; Lipps TD; Natarajan N; Brandyberry J; Wang Z; Sallee FR; Wassermann EM;
- Institution
- Division of Neurology, Cincinnati Children's Hospital Medical Center, and The University of Cincinnati, Department of Neurology, School of Medicine, OH 45229-3039, USA. d.gilbert@cchmc.org
- Journal
- Clin Neurophysiol. 2007 Aug;118(8):1835-41. Epub 2007 Jun 27.
- Abstract URL
- Click here to view abstract
8. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.
- Author
- Biederman J; Monuteaux MC; Spencer T; Wilens TE; Macpherson HA; Faraone SV;
- Institution
- Research Program in Pediatric Psychopharmacology and Adult ADHD, Department of Psychiatry, Massachusetts General Hospital, Boston 02114, USA. biederman@ helix.mgh.harvard.edu
- Journal
- Am J Psychiatry. 2008 May;165(5):597-603. Epub 2008 Mar 3.
- Abstract URL
- Click here to view abstract
9. Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder.
- Author
- Faraone SV;
- Institution
- SUNY Upstate Medical University, Child and Adolescent Psychiatry Research, 750 East Adams Street, Syracuse, NY 13210, USA. faraones@upstate.edu
- Journal
- Expert Opin Pharmacother. 2008 Jun;9(9):1565-74.
- Abstract URL
- Click here to view abstract
10. Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study.
- Author
- Bakken RJ; Paczkowski M; Kramer HP; Axelson AA; Williams DW; Malcolm SK; Sumner CR; Kelsey DK;
- Institution
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. Rosalie@lilly.com
- Journal
- Curr Med Res Opin. 2008 Feb;24(2):449-60.
- Abstract URL
- Click here to view abstract
Next: Clinical Trials
